Adam Hermawan

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 23

Top Venues

Asian Pacific journal of cancer prevention : APJCP

Pharmacogenomics

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

Nutrition and cancer

Universitas Gadjah Mada (BSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Universitas Gadjah Mada

Indonesia

BSC :: Pharmaceutical Sciences

Publications

Intan Ayu Lestari, I Made Rhamandana Putra, Nurul Fatimah, Navista Sri Octa Ujiantari, Dyaningtyas Dewi Pamungkas Putri, Adam Hermawan
Characterization of Potential Target Genes of Borneol in Increasing Trastuzumab Sensitivity in HER2+ Trastuzumab-Resistant Breast Cancer: Bioinformatics and In Vitro Studies. Asian Pacific journal of cancer prevention : APJCP 25 (5) (2024)
Adam Hermawan, Muthi Ikawati, Dyaningtyas Dewi Pamungkas Putri, Nurul Fatimah, Heri Himawan Prasetio
Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and In Vitro Experiments. Nutrition and cancer (2024)
Adam Hermawan, Muthi Ikawati, Dyaningtyas Dewi Pamungkas Putri, Nurul Fatimah, Heri Himawan Prasetio
Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and In Vitro Experiments. Nutrition and cancer 76 (7) (2024)
Hui Yin Yow, Muthi Ikawati, Soni Siswanto, Adam Hermawan, Alim Khodimul Rahmat, Janet Sui-Ling Tan, Ying Chew Tee, Kok-Peng Ng, Zullies Ikawati
Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review. Pharmacogenomics 25 (5-6) (2024)
Intan Ayu Lestari, I Made Rhamandana Putra, Nurul Fatimah, Navista Sri Octa Ujiantari, Dyaningtyas Dewi Pamungkas Putri, Adam Hermawan
Characterization of Potential Target Genes of Borneol in Increasing Trastuzumab Sensitivity in HER2+ Trastuzumab-Resistant Breast Cancer: Bioinformatics and In Vitro Studies. Asian Pacific journal of cancer prevention : APJCP 25 (5) (2024)
Dewa A S Handani, Adam Hermawan, Zullies Ikawati
Correlation of ACE insertion/deletion gene polymorphism with captopril effectiveness in Indonesian hypertensive patients. Pharmacogenomics (2024)
Intan Ayu Lestari, I Made Rhamandana Putra, Nurul Fatimah, Navista Sri Octa Ujiantari, Dyaningtyas Dewi Pamungkas Putri, Adam Hermawan
Characterization of Potential Target Genes of Borneol in Increasing Trastuzumab Sensitivity in HER2+ Trastuzumab-Resistant Breast Cancer: Bioinformatics and In Vitro Studies. Asian Pacific journal of cancer prevention : APJCP 25 (5) (2024)
Hui Yin Yow, Muthi Ikawati, Soni Siswanto, Adam Hermawan, Alim Khodimul Rahmat, Janet Sui-Ling Tan, Ying Chew Tee, Kok-Peng Ng, Zullies Ikawati
Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review. Pharmacogenomics (2024)
Hui Yin Yow, Muthi Ikawati, Soni Siswanto, Adam Hermawan, Alim Khodimul Rahmat, Janet Sui-Ling Tan, Ying Chew Tee, Kok-Peng Ng, Zullies Ikawati
Influence of genetic polymorphisms on pharmacokinetics and treatment response of mycophenolic acid: a scoping review. Pharmacogenomics 25 (5-6) (2024)
Adam Hermawan, Herwandhani Putri
Bioinformatics Analysis of the Genetic and Epigenetic Alterations of Bone Morphogenetic Protein Receptors in Metastatic Breast Cancer. Biochemical genetics (2023)
Gusti Putu Wahyunanda Crista Yuda, Naufa Hanif, Adam Hermawan
Computational Screening Using a Combination of Ligand-Based Machine Learning and Molecular Docking Methods for the Repurposing of Antivirals Targeting the SARS-CoV-2 Main Protease. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences (2023)
Wilfan Ibadurrahman, Naufa Hanif, Adam Hermawan
Functional network analysis of p85 and PI3K as potential gene targets and mechanism of oleanolic acid in overcoming breast cancer resistance to tamoxifen. Journal, genetic engineering & biotechnology 20 (1) (2022)
Skolastika Skolastika, Naufa Hanif, Muthi Ikawati, Adam Hermawan
Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Adam Hermawan, Herwandhani Putri
Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy. BMC genomic data 23 (1) (2022)
Salma Nur Azizah Azzahra, Naufa Hanif, Adam Hermawan
MDM2 is a Potential Target Gene of Glycyrrhizic Acid for Circumventing Breast Cancer Resistance to Tamoxifen: Integrative Bioinformatics Analysis. Asian Pacific journal of cancer prevention : APJCP 23 (7) (2022)
Adam Hermawan, Herwandhani Putri, Naufa Hanif, Muthi Ikawati
Integrative Bioinformatics Study of Tangeretin Potential Targets for Preventing Metastatic Breast Cancer. Evidence-based complementary and alternative medicine : eCAM 2021 (2021)
Moh Arikus Wibowo, Eri Prasetyo Nugroho, Adam Hermawan
Genomic Understanding Reveals the Important Role of FGFR2 as Paeoniflorin Target for Circumventing Breast Cancer Resistance to Tamoxifen. Asian Pacific journal of cancer prevention : APJCP 22 (12) (2021)
Adam Hermawan, Herwandhani Putri
Bioinformatics Studies Provide Insight into Possible Target and Mechanisms of Action of Nobiletin against Cancer Stem Cells. Asian Pacific journal of cancer prevention : APJCP 21 (3) (2020)
Adam Hermawan, Herwandhani Putri
Integrative Bioinformatics Analysis Reveals Potential Target Genes and TNFα Signaling Inhibition by Brazilin in Metastatic Breast Cancer Cells. Asian Pacific journal of cancer prevention : APJCP 21 (9) (2020)
Adam Hermawan, Muthi Ikawati, Annisa Khumaira, Herwandhani Putri, Riris Istighfari Jenie, Sonia Meta Angraini, Haruma Anggraini Muflikhasari
Bioinformatics and In Vitro Studies Reveal the Importance of p53, PPARG and Notch Signaling Pathway in Inhibition of Breast Cancer Stem Cells by Hesperetin. Advanced pharmaceutical bulletin 11 (2) (2020)
Ika Putri Nurhayati, Annisa Khumaira, Gagas Pradani Nur Ilmawati, Edy Meiyanto, Adam Hermawan
Cytotoxic and Antimetastatic Activity of Hesperetin and Doxorubicin Combination Toward Her2 Expressing Breast Cancer Cells. Asian Pacific journal of cancer prevention : APJCP 21 (5) (2020)
Adam Hermawan, Herwandhani Putri, Rohmad Yudi Utomo
Functional network analysis reveals potential repurposing of β-blocker atenolol for pancreatic cancer therapy. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 28 (2) (2020)
Adam Hermawan, Herwandhani Putri, Rohmad Yudi Utomo
Comprehensive bioinformatics study reveals targets and molecular mechanism of hesperetin in overcoming breast cancer chemoresistance. Molecular diversity 24 (4) (2019)

Adam Hermawan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Adam Hermawan